The Oncology Institute Stock Buy Hold or Sell Recommendation
| TOIIW Stock | USD 0.01 0.00 0.00% |
Assuming the 90 days horizon and your highly speculative risk level, our recommendation regarding The Oncology Institute is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell The Oncology Institute given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for The Oncology Institute, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Oncology Institute Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide. Note, we conduct extensive research on individual companies such as Oncology and provide practical buy, sell, or hold advice based on investors' constraints. The Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Oncology |
Execute Oncology Institute Buy or Sell Advice
The Oncology recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on The Oncology Institute. Macroaxis does not own or have any residual interests in The Oncology Institute or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Oncology Institute's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Oncology Institute Trading Alerts and Improvement Suggestions
| Oncology Institute is way too risky over 90 days horizon | |
| Oncology Institute has some characteristics of a very speculative penny stock | |
| Oncology Institute appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 324.24 M. Net Loss for the year was (83.07 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| The Oncology Institute has accumulated about 15.17 M in cash with (36.31 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Oncology institute director Brad Hively acquires 50,000 in stock - Investing.com |
Oncology Institute Returns Distribution Density
The distribution of Oncology Institute's historical returns is an attempt to chart the uncertainty of Oncology Institute's future price movements. The chart of the probability distribution of Oncology Institute daily returns describes the distribution of returns around its average expected value. We use The Oncology Institute price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Oncology Institute returns is essential to provide solid investment advice for Oncology Institute.
| Mean Return | 1.27 | Value At Risk | -27.03 | Potential Upside | 32.39 | Standard Deviation | 18.09 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Oncology Institute historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Oncology Institute Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (1.1M) | (465.2K) | (1.8M) | (1.7M) | (4.4M) | (4.2M) | |
| Investments | (1.2M) | (8.8M) | (12.2M) | (131.6M) | 18.4M | 19.4M | |
| Change In Cash | 2.4M | 3.6M | 109.2M | (101.2M) | 19.5M | 20.5M | |
| Free Cash Flow | 2.4M | (685.9K) | (35.7M) | (67.3M) | (40.9M) | (38.8M) | |
| Depreciation | 2.9M | 3.2M | 3.3M | 4.4M | 5.9M | 3.8M | |
| Other Non Cash Items | 326.9K | 11.9M | (33.9M) | (75.2M) | 20.8M | 21.8M | |
| Capital Expenditures | 1.2M | 1.2M | 3.0M | 5.5M | 4.6M | 3.0M | |
| Net Income | (4.0M) | (14.3M) | (10.9M) | 1.7M | (83.1M) | (78.9M) | |
| End Period Cash Flow | 2.4M | 6.0M | 115.2M | 14.0M | 33.5M | 31.4M |
Oncology Institute Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Oncology Institute or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Oncology Institute's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Oncology stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.46 | |
β | Beta against Dow Jones | -1.82 | |
σ | Overall volatility | 17.74 | |
Ir | Information ratio | 0.06 |
Oncology Institute Volatility Alert
The Oncology Institute is showing large volatility of returns over the selected time horizon. The Oncology Institute is a penny stock. Although Oncology Institute may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in The Oncology Institute. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Oncology instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Oncology Institute Fundamentals Vs Peers
Comparing Oncology Institute's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Oncology Institute's direct or indirect competition across all of the common fundamentals between Oncology Institute and the related equities. This way, we can detect undervalued stocks with similar characteristics as Oncology Institute or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Oncology Institute's fundamental indicators could also be used in its relative valuation, which is a method of valuing Oncology Institute by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Oncology Institute to competition |
| Fundamentals | Oncology Institute | Peer Average |
| Return On Equity | -1.26 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Profit Margin | (0.20) % | (1.27) % |
| Operating Margin | (0.17) % | (5.51) % |
| Number Of Shares Shorted | 2.64 K | 4.71 M |
| Revenue | 324.24 M | 9.43 B |
| EBITDA | (70.45 M) | 3.9 B |
| Net Income | (83.07 M) | 570.98 M |
| Cash And Equivalents | 15.17 M | 2.7 B |
| Total Debt | 119.67 M | 5.32 B |
| Debt To Equity | 0.1 % | 48.70 % |
| Current Ratio | 1.76 X | 2.16 X |
| Book Value Per Share | 0.77 X | 1.93 K |
| Cash Flow From Operations | (36.31 M) | 971.22 M |
| Earnings Per Share | (602.09) X | 3.12 X |
| Number Of Employees | 800 | 18.84 K |
| Beta | 0.62 | -0.15 |
| Total Asset | 209.24 M | 29.47 B |
| Retained Earnings | (146.15 M) | 9.33 B |
| Working Capital | 108.7 M | 1.48 B |
| Net Asset | 209.24 M |
Note: Disposition of 99998 shares by Havencrest Healthcare Partners, L.p. of Oncology Institute subject to Rule 16b-3 [view details]
Oncology Institute Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Oncology . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0125 | |||
| Day Typical Price | 0.0125 |
About Oncology Institute Buy or Sell Advice
When is the right time to buy or sell The Oncology Institute? Buying financial instruments such as Oncology Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Oncology Institute in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sovereign ETFs Thematic Idea Now
Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sovereign ETFs theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Oncology Stock Analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.